A host-tumor interaction-based five-dimensional risk stratification system integrating immune surveillance, inflammation, nutrition, coagulation, and tumor burden for prognostic evaluation in stage III colorectal cancer

Objective Stage III colorectal cancer (CRC) exhibits substantial prognostic heterogeneity, underscoring the need for robust risk stratification tools. We aimed to develop and validate a novel five-dimensional (5D) score integrating immune surveillance, inflammation, nutrition, coagulation, and tumor burden to improve prognostic assessment in these patients. Materials and methods We retrospectively enrolled 338 patients with stage III CRC, who were randomly assigned to a discovery cohort (n=228) and a validation cohort (n=110). Preoperative peripheral blood biomarkers were detected before surgery to construct the 5D score. Patients were followed for three years to assess recurrence-free survival (RFS) and overall survival (OS). Kaplan-Meier analysis, Cox proportional hazards regression, and time-dependent receiver operating characteristic (ROC) curve analyses were performed to evaluate the prognostic performance of the score. Results Low levels of the combined lymphocyte-eosinophil-basophil immune- surveillance axis and prealbumin, together with elevated monocyte counts, fibrinogen, and the combined CEA-CA19–9 score, were significantly associated with inferior survival. The 5D score showed a strong stepwise association with both RFS and OS (plog-rank<0.001). Multivariate Cox regression analysis identified the 5D risk stratification system as an independent prognostic factor in both the discovery and validation cohorts and across age-stratified subgroups. Time-dependent ROC analyses demonstrated that the score achieved superior predictive performance for RFS and OS compared with biomarkers representing any single biological dimension. Furthermore, patients with low- and intermediate-risk scores appeared to benefit from the oxaliplatin-plus-capecitabine regimen, whereas those with ultra-high-risk scores experienced poor survival despite standard treatment. Conclusions The 5D score is a simple, cost-effective, and robust prognostic tool for patients with stage III CRC. By integrating complementary dimensions of host-tumor interactions, the 5D score may improve preoperative risk stratification and support individualized postoperative surveillance and treatment decisions. Prospective multi-center studies are warranted to further validate its clinical utility and biological significance.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-12
DOI
https://doi.org/10.3389/fimmu.2026.1925900
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A host-tumor interaction-based five-dimensional risk stratification system integrating immune surveillance, inflammation, nutrition, coagulation, and tumor burden for prognostic evaluation in stage III colorectal cancer

Hou‐Qun Ying, Zijin Xia, Qiu-Ying Ye, Xiao-Yan Tang et al.
Frontiers in Immunology
Inflammatory Biomarkers in Disease Prognosis
article

A host-tumor interaction-based five-dimensional risk stratification system integrating immune surveillance, inflammation, nutrition, coagulation, and tumor burden for prognostic evaluation in stage III colorectal cancer

Hou‐Qun Ying, Zijin Xia, Qiu-Ying Ye, Xiao-Yan Tang, Yue Peng, Wan-Lei Sun
article en

Abstract

Objective Stage III colorectal cancer (CRC) exhibits substantial prognostic heterogeneity, underscoring the need for robust risk stratification tools. We aimed to develop and validate a novel five-dimensional (5D) score integrating immune surveillance, inflammation, nutrition, coagulation, and tumor burden to improve prognostic assessment in these patients. Materials and methods We retrospectively enrolled 338 patients with stage III CRC, who were randomly assigned to a discovery cohort (n=228) and a validation cohort (n=110). Preoperative peripheral blood biomarkers were detected before surgery to construct the 5D score. Patients were followed for three years to assess recurrence-free survival (RFS) and overall survival (OS). Kaplan-Meier analysis, Cox proportional hazards regression, and time-dependent receiver operating characteristic (ROC) curve analyses were performed to evaluate the prognostic performance of the score. Results Low levels of the combined lymphocyte-eosinophil-basophil immune- surveillance axis and prealbumin, together with elevated monocyte counts, fibrinogen, and the combined CEA-CA19–9 score, were significantly associated with inferior survival. The 5D score showed a strong stepwise association with both RFS and OS (plog-rank<0.001). Multivariate Cox regression analysis identified the 5D risk stratification system as an independent prognostic factor in both the discovery and validation cohorts and across age-stratified subgroups. Time-dependent ROC analyses demonstrated that the score achieved superior predictive performance for RFS and OS compared with biomarkers representing any single biological dimension. Furthermore, patients with low- and intermediate-risk scores appeared to benefit from the oxaliplatin-plus-capecitabine regimen, whereas those with ultra-high-risk scores experienced poor survival despite standard treatment. Conclusions The 5D score is a simple, cost-effective, and robust prognostic tool for patients with stage III CRC. By integrating complementary dimensions of host-tumor interactions, the 5D score may improve preoperative risk stratification and support individualized postoperative surveillance and treatment decisions. Prospective multi-center studies are warranted to further validate its clinical utility and biological significance.

Frontiers in ImmunologyVol. 17
Nanchang University (CN), Sun Yat-sen University (CN), National University of Singapore (SG), Second Affiliated Hospital of Nanchang University (CN), Second Hospital of Nanchang (CN), Jiangxi Medical College (CN)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon